BriaCell Therapeutics BCTX Income Statement (2019-2026)

NASDAQ BCTX
$4.08 -0.08 (-1.81%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

BriaCell Therapeutics Quarterly Income Statement

Periods 24 quarters
Latest Apr 2026

BriaCell Therapeutics reported net income of -$7.43M for the quarter ended Apr 2026. This income statement covers 24 quarters of results from Aug 2019 through Apr 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Aug2019 Jul2020 Jan2021 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Shares Outstanding (Entity)Shares Outstanding (Entity.)
0.03M0.10M0.11M0.10M0.10M0.10M0.10M0.10M0.11M0.11M0.11M0.11M0.12M0.18M0.29M0.37M0.42M1.88M2.80M7.25M
Operating items
Research & DevelopmentR&D
0.58M0.88M1.71M2.27M3.17M3.26M3.05M3.86M5.17M6.86M8.26M7.66M4.41M3.67M5.68M4.81M7.11M6.68M6.05M5.97M
Share-based Compensation (IS)
1.10M1.59M
Selling, General & AdministrativeSG&A
1.02M1.41M1.94M1.85M2.07M2.15M1.43M1.82M2.54M1.65M1.57M1.57M1.36M1.49M1.48M1.52M1.44M1.64M1.48M1.65M
Rent ExpenseRental Exp.
0.03M0.04M
Other Operating ExpensesOther Opex
-0.00M-0.03M-0.04M
Operating ExpensesOpex
1.60M2.28M3.65M4.12M5.23M5.40M4.49M5.68M7.71M8.50M9.83M9.23M5.77M5.15M7.17M6.33M8.55M8.32M7.53M7.62M
Operating IncomeOp. Inc
-1.60M-2.28M-3.65M-4.12M-5.23M-5.40M-4.49M-5.68M-7.71M-8.50M-9.83M-9.23M-5.77M-5.15M-7.17M-6.33M-8.55M-8.32M-7.53M-7.62M
EBIT
-1.60M-2.28M-3.65M-4.12M-5.23M-5.40M-4.49M-5.68M-7.71M-8.50M-9.83M-9.23M-5.77M-5.15M-7.17M-6.33M-8.55M-8.32M-7.53M-7.62M
Non-operating items
Non Operating Interest Expenses
-0.08M979.000.04M0.03M
Non Operating Investment Income
0.09M0.14M
Interest & Investment IncomeInt & Inv Inc
0.01M0.01M0.04M0.08M0.19M0.24M0.25M0.21M0.19M0.08M0.02M2.000.01M0.05M0.03M0.03M0.05M0.11M0.22M
Other Non Operating IncomeOther Non Op Inc.
17.84M25.25M-14.80M5.93M-4.73M-4.12M7.63M-0.54M-5.09M-14.28M1.57M-10.95M-4.58M0.62M-0.81M-0.18M-0.39M0.07M-0.21M-0.12M
Non Operating IncomeNon Op. Inc.
-25.25M14.81M-5.89M4.78M4.30M-7.40M0.78M3.17M0.18M0.08M0.01M-0.01M0.01M0.07M-0.01M0.05M0.16M0.08M0.19M
Net income details
EBT
-1.52M-2.28M-3.63M-4.09M-5.15M-5.21M-4.25M-5.42M-7.50M-8.31M-9.75M-9.21M-5.77M-5.14M-7.12M-6.34M-8.52M-8.27M-7.43M-7.43M
Profit After TaxPAT
-1.52M-2.28M-3.63M-4.09M-5.15M-5.21M-4.25M-5.42M-7.50M-8.31M-9.75M-9.21M-5.77M-5.14M-7.12M-6.34M-8.52M-8.27M-7.43M-7.43M
Equity Income
-0.02M-0.04M-0.05M-0.07M-0.04M-0.06M-0.05M-0.04M-0.06M-0.06M
Income from Non-Controlling InterestsInc. Minority
-0.04M-0.04M-0.02M-0.03M-0.03M-0.05M-0.10M-0.07M-0.08M-0.08M-0.07M
Income from Continuing OperationsIncome (Continuing)
-1.52M-2.28M-3.63M-4.09M-5.15M-5.21M-4.25M-5.42M-7.50M-8.31M-9.75M-9.21M-5.77M-5.14M-7.12M-6.34M-8.52M-8.27M-7.43M-7.43M
Consolidated Net IncomeConsol Net Inc.
-2.72M-2.28M-3.87M-4.84M-5.15M-1.11M-11.88M-4.90M-2.42M5.96M-11.33M1.69M-1.25M-5.83M-6.34M-6.22M-8.16M-8.28M-7.30M-7.24M
Income towards Parent CompanyParent Net Inc
-2.72M-27.53M-3.87M-10.02M11.16M-1.11M-11.88M-4.90M-2.42M6.00M-11.29M1.72M-1.21M-5.80M-6.29M-6.13M-8.09M-8.20M-7.22M-7.16M
Net Income towards Common StockholdersNet Income
-2.72M-27.53M-3.87M-10.02M11.16M-1.11M-11.88M-4.90M-11.88M-8.28M-11.29M1.72M2.99M-5.80M-6.29M-6.13M-8.09M-8.20M-7.22M-7.16M
Additional items
EPS (Basic)
-90.29-271.01-36.72-97.81108.04-10.70-114.85-47.32-114.10-77.72-106.0016.1027.23-32.67-23.31-16.40-19.12-4.35-2.58-0.99
EPS (Diluted)
-90.29-913.76-31.50-97.81108.04-10.70-114.85-47.32-114.10-74.48-106.0016.1027.23-32.67-23.31-16.40-19.12-4.35-2.58-0.99
Shares Outstanding
0.03M0.10M0.11M0.10M0.10M0.10M0.10M0.10M0.10M0.11M0.11M0.11M0.11M0.18M0.27M0.37M0.42M1.88M2.80M7.25M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
0.03M0.03M0.12M0.10M0.10M0.10M0.10M0.10M0.10M0.11M0.11M0.11M0.11M0.18M0.27M0.37M0.42M1.88M2.80M7.25M
EBITDA
-1.60M-2.28M-3.64M-4.12M-5.23M-5.40M-4.48M-5.67M-8.50M-9.83M-9.23M-5.71M-5.13M-7.14M-6.30M-8.54M-8.30M-7.50M-7.59M
Interest ExpensesInt Expense
-0.08M979.000.04M0.03M

BriaCell Therapeutics Income Statement API

Pull BriaCell Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BCTX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY